Intra Cellular Therapies | SCHULD



Debt Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2024-12
ALKERMES USD 0 366M 2024-12
Biogen USD 6.3B 1.9M 2024-12
Bristol-Myers Squibb USD 49.65B 103M 2024-12
Cytokinetics USD 657.12M 1.1M 2024-12
Gilead Sciences USD 26.71B 3.46B 2024-12
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
J&J USD 36.63B 883M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 31.26B 828M 2024-12
Prothena USD 0 0 2024-12
RedHill Biopharma USD 558K 615K 2024-06
Supernus Pharmaceuticals USD 0 0 2024-12
United Therapeutics USD 300M 100M 2024-12



Intra Cellular Therapies SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.